Physician profile
Robert C Vercio
NPI 1477972651
$3,675.50
in general payments reported to CMS, 2019-2025
25 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,499 · 2021: $1,267 · 2022: $143 · 2023: $304 · 2024: $56.11 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sportstek Medical, INC | $1,300.00 | 2019 | |
| Great Lakes Orthopedics | $1,200.00 | 2021 | |
| Stryker Corporation | $213.10 | 2019-2025 | Pangea, Variax, Latitude Ev |
| Axogen | $101.54 | 2023-2025 | Avance Nerve Graft |
| Polynovo North America LLC | $91.34 | 2023 | |
| Ferring Pharmaceuticals INC. | $73.34 | 2022-2023 | Euflexxa |
| Merck Sharp & Dohme LLC | $70.27 | 2021-2025 | Bridion |
| Pfizer INC. | $61.69 | 2025 | |
| Heron Therapeutics, INC. | $59.34 | 2021-2023 | Aponvie |
| Bioventus LLC | $56.43 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Anika Therapeutics, INC. | $56.37 | 2023 | Hemicap, Wristmotion |
| Amgen INC. | $43.02 | 2025 | Evenity, Prolia |
| Sonex Health, INC. | $40.23 | 2025 | Sx-One Microknife |
| Orthofix Medical, INC. | $37.48 | 2022-2024 | Physio-Stim |
| Avanos Medical | $36.26 | 2024 | On-Q* Pump and Accessories |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fx Shoulder Solutions, INC | $32.12 | 2025 | |
| Trice Medical, INC. | $29.44 | 2023 | |
| Fidia Pharma USA INC. | $25.21 | 2025 | Triluron, Hymovis |
| Zimvie INC. | $24.00 | 2022 | |
| Becton, Dickinson and Company | $23.76 | 2022 | |
| Linvatec Corporation | $23.33 | 2025 | Biobrace 23mm |
| Vertex Pharmaceuticals Incorporated | $21.71 | 2025 | |
| Convatec INC. | $20.52 | 2025 | |
| Nuvasive Specialized Orthopedics, INC. | $18.45 | 2019 | |
| Depuy Synthes Sales INC. | $16.55 | 2025 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Vercio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.